Skip to main content

NF1 Germline and Somatic Mosaicism

  • Chapter
  • First Online:
Neurofibromatosis Type 1

Abstract

NF1 affects ~1/3,000 individuals, irrespective of gender or ethnic background, and as many as 30–50 % of these patients present as “sporadic” or “founder” patients. A small fraction of these “sporadic” patients present with mosaicism for a “first hit” NF1 mutation. The precise frequency of mosaicism in NF1 is unknown, but first estimates indicate it may affect ~10 % of the patients with a total gene deletion. Here, we provide an overview of the different forms of mosaicism: gonadal or germline mosaicism, gonosomal mosaicism affecting both gonads and somatic cells, and somatic mosaicism, which may be “generalized” in phenotypic appearance or “localized” with a “segmental” distribution. Revertant mosaicism is discussed as well, though it has not yet been demonstrated in NF1 patients. Molecular data reported in the literature, proving the presence of an NF1 “first hit” mutation affecting only a portion of the body cells, depending on the timing of the mutational “first hit” during development, are summarized and the mutational spectrum and phenotype identified in mosaic NF1 patients are reviewed. The implications of our current understanding of mosaicism for molecular diagnostics in NF1 are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ainsworth P, Chakraborty P, Weksberg R (1997) Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion. Hum Mutat 9:452–459.

    Article  PubMed  CAS  Google Scholar 

  • Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851–860

    Article  PubMed  CAS  Google Scholar 

  • Beert E, Brems H, Renard M, Ferreiro J, Melotte C, Thoelen R, De Wever I, Sciot R, Legius E, Debiec-Rychter M (2012) Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma. Genes Chromosomes Cancer 51:852–857

    Google Scholar 

  • Bottillo I, Torrente I, Lanari V, Pinna V, Giustini S, Divona L, De Luca A, Dallapiccola B (2010) Germline mosaicism in neurofibromatosis type 1 due to a paternally derived multi-exon deletion. Am J Med Genet A 152A:1467–1540.

    PubMed  CAS  Google Scholar 

  • Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns J-P, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E (2007) Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39:1120–1126.

    Article  PubMed  CAS  Google Scholar 

  • Brems H, Beert E, de Ravel T, Legius E (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10:508–523.

    Article  PubMed  CAS  Google Scholar 

  • Brems H, Pasmant E, Van Minkelen R, Wimmer K, Upadhyaya M, Legius E, Messiaen L (2012) Review and update of SPRED1 mutations causing Legius syndrome. Hum Mutat 33(11):1538–1546.

    Google Scholar 

  • Callum P, Messiaen L, Bower P, Skovby F, Iger J, Timshel S, Sims C, Falk R (2012) Gonosomal mosaicism for an NF1 deletion in a sperm donor: evidence of the need for coordinated, long-term communication of health information among relevant parties. Hum Reprod 27:1223–1229.

    Article  PubMed  CAS  Google Scholar 

  • Castori M, Majore S, Romanelli F, Didona B, Grammatico P, Zambruno G (2008) Association of segmental neurofibromatosis 1 and oculo-auriculo-vertebral spectrum in a 24-year-old female. Eur J Dermatol 18:22–27.

    PubMed  Google Scholar 

  • Colman S, Rasmussen S, Ho V, Abernathy C, Wallace M (1996) Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet 58:484–574

    PubMed  CAS  Google Scholar 

  • Consoli C, Moss C, Green S, Balderson D, Cooper DN, Upadhyaya M (2005) Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol 125:463–469.

    Article  PubMed  CAS  Google Scholar 

  • De Schepper S, Maertens O, Callens T, Naeyaert J-M, Lambert J, Messiaen L (2008) Somatic mutation analysis in NF1 café au lait spots reveals two NF1 hits in the melanocytes. J Invest Dermatol 128:1050–1053.

    Article  PubMed  Google Scholar 

  • Evans D, Howard E, Giblin C, Clancy T, Spencer H, Huson S, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327–359.

    Article  PubMed  CAS  Google Scholar 

  • Fernández-Rodríguez J, Castellsagué J, Benito L, Benavente Y, Capellá G, Blanco I, Serra E, Lázaro C (2011) A mild neurofibromatosis type 1 phenotype produced by the combination of the benign nature of a leaky NF1-splice mutation and the presence of a complex mosaicism. Hum Mutat 32:705–714.

    Article  PubMed  Google Scholar 

  • Fortino S, Andre M, Sudish M, Nicholas MB (2005) Thoracoscopically guided transaxillary resection of adjoining intercostal plexiform neurofibromas: review of mosaicism in neurofibromatosis: technical note. Neurosurgery 57 (4 Suppl):E407

    Google Scholar 

  • Friedman J (1999) Vascular and endocrine abnormalities. In: Friedman JM, Gutmann DH, AmcCollin M, Riccardi VM (eds) Neurofibromatosis. Phenotype, natural history, and pathogenesis. Johns Hopkins University Press, Baltimore, MD, pp 274–296

    Google Scholar 

  • Hager C, Cohen P, Tschen J (1997) Segmental neurofibromatosis: case reports and review. J Am Acad Dermatol 37:864–873

    Article  PubMed  CAS  Google Scholar 

  • Havlovicova M, Novotna D, Kocarek E, Novotna K, Bendova S, Petrak B, Hrdlicka M, Sedlacek Z (2007) A girl with neurofibromatosis type 1, atypical autism and mosaic ring chromosome 17. Am J Med Genet A 143:76–157.

    PubMed  Google Scholar 

  • Huson SM, Ruggieri M (2000) The neurofibromatosis. In: Harper J, Oranje JM, Rose M (eds) Textbook of pediatric dermatology, vol 2. Blackwell, Oxford, pp 1204–1224

    Google Scholar 

  • Huson S, Compston D, Harper P (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales II. Guidelines for genetic counselling. J Med Genet 26:712–733

    Article  PubMed  CAS  Google Scholar 

  • Ingordo V, D’Andria G, Mendicini S, Grecucci M, Baglivo A (1995) Segmental neurofibromatosis: is it uncommon or underdiagnosed? Arch Dermatol 131:959–1019

    Article  PubMed  CAS  Google Scholar 

  • Kaplan L, Foster R, Shen Y, Parry D, McMaster M, O’Leary M, Gusella J (2010) Monozygotic twins discordant for neurofibromatosis 1. Am J Med Genet A 152A:601–607.

    Article  PubMed  Google Scholar 

  • Kehrer-Sawatzki H, Cooper DN (2008) Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? J Med Genet 45:622–653.

    Article  PubMed  CAS  Google Scholar 

  • Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer K, Krammer U, Peyrl A, Jenne D, Hansmann I, Mautner VF (2004) High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet 75:410–433.

    Article  PubMed  CAS  Google Scholar 

  • Kehrer-Sawatzki H, Vogt J, Mußotter T, Kluwe L, Cooper DN, Mautner V-F (2012) Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions. Neurogenetics 13:229–236

    Google Scholar 

  • Korf B (1999) Plexiform neurofibromas. Am J Med Genet 89:31–38

    Article  PubMed  CAS  Google Scholar 

  • Lai-Cheong J, McGrath J, Uitto J (2011) Revertant mosaicism in skin: natural gene therapy. Trends Mol Med 17:140–148.

    Article  PubMed  Google Scholar 

  • Lázaro C, Gaona A, Lynch M, Kruyer H, Ravella A, Estivill X (1995) Molecular characterization of the breakpoints of a 12-kb deletion in the NF1 gene in a family showing germ-line mosaicism. Am J Hum Genet 57:1044–1053

    PubMed  Google Scholar 

  • Lázaro C, Ravella A, Gaona A, Volpini V, Estivill X (1994) Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father. New Engl J Med 331:1403–1410.

    Article  PubMed  Google Scholar 

  • Listernick R, Mancini A, Charrow J (2003) Segmental neurofibromatosis in childhood. Am J Med Genet A 121A:132–137.

    Article  PubMed  Google Scholar 

  • Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T, De Schepper S, De Paepe A, Mortier G, Janssens S, Speleman F, Legius E, Messiaen L (2006) Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 27:1030–1070.

    Article  PubMed  CAS  Google Scholar 

  • Maertens O, De Schepper S, Vandesompele J, Brems H, Heyns I, Janssens S, Speleman F, Legius E, Messiaen L (2007) Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet 81:243–294.

    Article  PubMed  CAS  Google Scholar 

  • Mautner VF, Kluwe L, Friedrich RE, Roehl AC, Bammert S, Hogel J, Spori H, Cooper DN, Kehrer-Sawatzki H (2010) Clinical characterization of 29 neurofibromatosis type 1 patients with molecularly ascertained 1.4 Mb type-1 deletions. J Med Genet 47:623–630

    Article  PubMed  CAS  Google Scholar 

  • Messiaen L, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe A (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541–596.

    Article  PubMed  CAS  Google Scholar 

  • Messiaen L, Wimmer K (2008) NF1 mutational spectrum. In: Kaufmann D (ed) Monographs in human genetics, vol 16. Karger, Basel, pp 63–77

    Google Scholar 

  • Messiaen L, Yao S, Brems H, Callens T, Sathienkijkanchai A, Denayer E, Spencer E, Arn P, Babovic-Vuksanovic D, Bay C, Bobele G, Cohen B, Escobar L, Eunpu D, Grebe T, Greenstein R, Hachen R, Irons M, Kronn D, Lemire E, Leppig K, Lim C, McDonald M, Narayanan V, Pearn A, Pedersen R, Powell B, Shapiro L, Skidmore D, Tegay D, Thiese H, Zackai E, Vijzelaar R, Taniguchi K, Ayada T, Okamoto F, Yoshimura A, Parret A, Korf B, Legius E (2009) Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA 302:2111–2119.

    Article  PubMed  CAS  Google Scholar 

  • Messiaen L, Vogt J, Bengesser K, Fu C, Mikhail F, Serra E, Garcia-Linares C, Cooper DN, Lazaro C, Kehrer-Sawatzki H (2011) Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat 32:213–222.

    Article  PubMed  CAS  Google Scholar 

  • Morais P, Ferreira O, Bettencourt H, Azevedo F (2010) Segmental neurofibromatosis: a rare variant of a common genodermatosis. Acta Dermatovenerol Alp Panonica Adriat 19:27–36

    PubMed  CAS  Google Scholar 

  • Muram-Zborovski T, Vaughn C, Viskochil D, Hanson H, Mao R, Stevenson D (2010) NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1. Am J Med Genet A 152A:1973–1981.

    Article  PubMed  CAS  Google Scholar 

  • Oguzkan S, Cinbis M, Ayter S, Anlar B, Aysun S (2004) Familial segmental neurofibromatosis. J Child Neurol 19:392–396

    Article  PubMed  Google Scholar 

  • Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J (2008) Segmental neurofibromatosis type 1 (NF1) associated with Cobb syndrome: case report. Neuropediatrics 39:341–343

    Google Scholar 

  • Petek E, Jenne D, Smolle J, Binder B, Lasinger W, Windpassinger C, Wagner K, Kroisel P, Kehrer-Sawatzki H (2003) Mitotic recombination mediated by the JJAZF1 (KIAA0160) gene causing somatic mosaicism and a new type of constitutional NF1 microdeletion in two children of a mosaic female with only few manifestations. J Med Genet 40:520–525

    Article  PubMed  CAS  Google Scholar 

  • Poyhonen M, Kytölä S, Leisti J (2000) Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland. J Med Genet 37:632–638

    Article  PubMed  CAS  Google Scholar 

  • Rasmussen S, Colman S, Ho V, Abernathy C, Arn P, Weiss L, Schwartz C, Saul R, Wallace M (1998) Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet 35:468–539

    Article  PubMed  CAS  Google Scholar 

  • Rieley M, Stevenson D, Viskochil D, Tinkle B, Martin L, Schorry E (2011) Variable expression of neurofibromatosis 1 in monozygotic twins. Am J Med Genet A 155A:478–563.

    PubMed  Google Scholar 

  • Riva P, Corrado L, Natacci F, Castorina P, Wu B, Schneider G, Clementi M, Tenconi R, Korf B, Larizza L (2000) NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet 66:100–109.

    Article  PubMed  CAS  Google Scholar 

  • Roehl A, Mussotter T, Cooper DN, Kluwe L, Wimmer K, Högel J, Zetzmann M, Vogt J, Mautner V-F, Kehrer-Sawatzki H (2012) Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/−) stem cells. Hum Mutat 33:541–591.

    Article  PubMed  CAS  Google Scholar 

  • Rubenstein A, Bader J, Aron A, Wallace S (1983) Familial transmission of segmental neurofibromatosis. Neurology 33:76

    Google Scholar 

  • Ruggieri M, Huson S (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433–1476

    Article  PubMed  CAS  Google Scholar 

  • Schultz E, Kaufmann D, Tinschert S, Schell H, von den Driesch P, Schuler G (2002) Segmental neurofibromatosis. Dermatology 204:296–303

    Article  PubMed  Google Scholar 

  • Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard H, Lázaro C (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 9:3055–3119

    Article  PubMed  CAS  Google Scholar 

  • Steinmann K, Cooper DN, Kluwe L, Chuzhanova N, Senger C, Serra E, Lazaro C, Gilaberte M, Wimmer K, Mautner V-F, Kehrer-Sawatzki H (2007) Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. Am J Hum Genet 81:1201–1221.

    Article  PubMed  CAS  Google Scholar 

  • Steinmann K, Kluwe L, Cooper DN, Brems H, De Raedt T, Legius E, Mautner V-F, Kehrer-Sawatzki H (2008) Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletions. Eur J Hum Genet 16:572–652.

    Article  PubMed  CAS  Google Scholar 

  • Stevenson D, Zhou H, Ashrafi S, Messiaen L, Carey J, D’Astous J, Santora S, Viskochil D (2006) Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 79:143–151.

    Article  PubMed  CAS  Google Scholar 

  • Streubel B, Latta E, Kehrer-Sawatzki H, Hoffmann G, Fonatsch C, Rehder H (1999) Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2. Am J Med Genet 87:12–18

    Article  PubMed  CAS  Google Scholar 

  • Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, Thiel G, Jenne D (2000) Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 8:455–464.

    Article  PubMed  CAS  Google Scholar 

  • Tonsgard J, Yelavarthi K, Cushner S, Short M, Lindgren V (1997) Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet 73:80–86.

    Article  PubMed  CAS  Google Scholar 

  • Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, Mudd S, Pentinnen M, Cordeiro I, Ponder M, Ponder BA, Krwaczak M, Cooper DN (1998) Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 102:591–597

    Article  PubMed  CAS  Google Scholar 

  • Upadhyaya M, Huson S, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans D, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet J, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L (2007) An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 80:140–191.

    Article  PubMed  CAS  Google Scholar 

  • Valero MC, Martin Y, Hernandez-Imaz E, Hernandez AM, Melean G, Valero AM, Rodriguez-Alvaraez FJ, Telleria D, Hernandez-Chico C (2011) A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn 13:113–122

    Article  PubMed  CAS  Google Scholar 

  • Vandenbroucke I, van Doorn R, Callens T, Cobben J, Starink T, Messiaen L (2004) Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet 114:284–374.

    Article  PubMed  Google Scholar 

  • Vogt J, Kohlhase J, Morlot S, Kluwe L, Mautner V-F, Cooper D, Kehrer-Sawatzki H (2011) Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation. Hum Mutat 32:47.

    Article  Google Scholar 

  • Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, Legius E, Callens T, Beiglböck H, Maertens O, Messiaen L (2006) Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 45:265–276.

    Article  PubMed  CAS  Google Scholar 

  • Wolkenstein P, Mahmoudi A, Zeller J, Revuz J (1995) More on the frequency of segmental neurofibromatosis. Arch Dermatol 131:1465

    PubMed  CAS  Google Scholar 

  • Wu B, Boles R, Yaari H, Weremowicz S, Schneider G, Korf B (1997) Somatic mosaicism for deletion of the entire NF1 gene identified by FISH. Hum Genet 99:209–222

    Article  PubMed  CAS  Google Scholar 

  • Xu G, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63:835–876

    Article  PubMed  CAS  Google Scholar 

  • Zlotogora J (1993) Mutations in von Recklinghausen neurofibromatosis: a hypothesis. Am J Med Genet 46:182–186.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ludwine Messiaen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Messiaen, L., Xie, J. (2012). NF1 Germline and Somatic Mosaicism. In: Upadhyaya, M., Cooper, D. (eds) Neurofibromatosis Type 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-32864-0_12

Download citation

Publish with us

Policies and ethics